Low Libido: Hormonal, Metabolic & Psychological Causes

Hormonal Causes of Low Libido

Low testosterone: The most common hormonal cause in men. Free testosterone below 50 pg/mL (men) or below 1.5 pg/mL (women) is associated with reduced desire. Testosterone replacement consistently improves libido in hypogonadal men (Endocrine Society, 2018).

Estrogen changes: In women, declining estrogen (perimenopause/menopause) causes vaginal dryness and atrophy, making intercourse uncomfortable and reducing desire. Low estrogen also decreases genital blood flow.

Elevated prolactin: Hyperprolactinemia suppresses GnRH, reducing both testosterone and estrogen. Causes include pituitary adenomas, medications (antipsychotics, SSRIs, metoclopramide), and hypothyroidism.

Thyroid dysfunction: Both hypothyroidism and hyperthyroidism are associated with sexual dysfunction. Hypothyroidism reduces desire; hyperthyroidism can cause premature ejaculation in men.

Cortisol excess: Chronic stress suppresses sex hormones and shifts neurochemistry from 'rest and reproduce' (parasympathetic) to 'fight or flight' (sympathetic) — effectively turning off sexual desire as a survival mechanism.

Medications That Lower Libido

• SSRIs and SNRIs — Sexual side effects in 40-65% of users; serotonin elevation suppresses dopamine-driven desire
• Hormonal contraceptives — Increase SHBG by 200-400%, dramatically reducing free testosterone in women
• Beta-blockers — Reduce sympathetic arousal and may lower testosterone
• Opioids — Suppress GnRH; hypogonadism in 50-90% of chronic users
• Finasteride/dutasteride — 5-alpha-reductase inhibitors reduce DHT, a potent androgen for sexual function
• Statins — May lower testosterone modestly by reducing cholesterol (the precursor to all steroid hormones)
• Spironolactone — Anti-androgen effects reduce libido in both sexes

Testing for Low Libido

A comprehensive evaluation includes:

Metabolic and Vascular Causes of Low Libido

Hormones aren't the only pathway — insulin resistance drives low libido through blood vessels, not just hormones. Sexual arousal depends on nitric oxide widening the small arteries that supply the genitals; insulin resistance impairs the same phosphatidylinositol 3-kinase signaling pathway that normally triggers that nitric oxide release, so the vessels dilate less even when desire is otherwise present. Chronically elevated insulin also promotes low-grade arterial inflammation and, over years, atherosclerosis, both of which further restrict genital blood flow.

This is why erectile or arousal difficulty can be the earliest visible sign of insulin resistance in an otherwise-healthy-seeming man or woman, often preceding a diabetes diagnosis by years — several clinical studies have found insulin resistance is an independent predictor of erectile dysfunction severity in men, separate from age, cholesterol, or blood pressure. It also compounds the hormonal picture above: insulin resistance is separately associated with lower free testosterone and higher estrogen in men, and with irregular cycles and reduced desire in women (frequently as part of PCOS). A fasting insulin or HOMA-IR panel is worth adding to the hormone workup above when libido decline shows up alongside weight gain, fatigue, or a family history of type 2 diabetes — see insulin resistance warning signs for the fuller symptom picture.

Visceral (abdominal) fat is the tissue most tightly linked to this pathway, since it is more metabolically active and more insulin-resistant than fat stored elsewhere on the body. Visceral fat also secretes inflammatory signaling proteins and raises aromatase activity, which converts testosterone into estrogen and adds a hormonal drag on top of the vascular one. That combination is why waist circumference tracks erectile and libido complaints more closely than total body weight or BMI in observational research. See our guide to visceral fat for the disease-risk mechanisms and how it's measured, and visceral fat symptoms for how to tell it apart from ordinary bloating on self-exam.

The Dual Control Model: Why Two People With the Same Testosterone Level Can Feel Different Levels of Desire

Testosterone sets the ceiling for sexual interest. It does not decide whether desire shows up in a given moment. Researchers explain this gap with the dual control model.

Every person runs two systems at once: excitation and inhibition. Desire is what's left after the two systems cancel out. The excitation system runs on dopamine in the brain's reward circuit, called the mesolimbic pathway.

Testosterone raises the volume on that dopamine circuit. The inhibition system runs on serotonin, cortisol, and threat-detection circuitry. A strong inhibition signal can override strong excitation entirely.

This explains something clinicians see often. Two people with the same free testosterone level can report very different desire. One simply has a quieter inhibition system than the other.

It also explains why SSRIs blunt desire in most users. Testosterone often stays normal on these drugs. Serotonin still dampens the dopamine signal that excitation depends on.

How Low Libido Differs Between Men and Women

The hormonal picture overlaps between the sexes, but the thresholds differ. In men, desire tracks free testosterone fairly closely. The decline after age 40, roughly 1-2% a year, feels like a slow fade rather than a sudden drop.

In women, desire depends on the balance of testosterone, estrogen, and DHEA. No single number predicts it well. This is why testosterone therapy alone helps some women and not others.

Perimenopause adds a second layer for women. Estrogen swings, not just its eventual decline, can disrupt desire early. This can happen years before menopause itself begins.

Physical causes diverge too. In men, reduced genital blood flow shows up first as erectile changes. In women, the same vascular and estrogen-driven changes show up as vaginal dryness and pain with intercourse.

That pain can suppress desire indirectly. Sex becomes something to avoid rather than something the body responds to. A workup for low libido reflects this difference: women typically start with a pelvic exam and bloodwork, men typically start with morning testosterone and an erectile-function history.

What to Actually Do About Medication-Induced Low Libido

Knowing that an SSRI is blunting desire does not make it go away, and stopping an antidepressant on your own is not the right first move. Three approaches typically outperform doing nothing: adding bupropion, which does not carry the same sexual side effect and sometimes offsets it when taken alongside an SSRI; switching to an antidepressant with a lower reported rate of sexual dysfunction; or a scheduled dose adjustment timed with your prescriber, never skipped on your own. None of these fixes work if you handle it alone. Bring the specific complaint to whoever prescribes the medication, not just to whoever manages your hormones, since the fix usually sits on the psychiatric side of the chart even when the symptom shows up in the bedroom.

Blood Draw Timing and Protocols for Testosterone Testing

Testosterone blood tests must be drawn in the early morning while fasting to prevent false readings caused by daily hormone swings. In men, serum testosterone follows a diurnal rhythm that peaks shortly after waking and declines across the afternoon. An afternoon sample can register substantially lower than a morning draw from the same person.

That drop reflects routine circadian timing instead of a loss of baseline hormone production. Women experience daily and cycle-related hormonal variations as well, though the morning peak has the clearest clinical guideline support in men. A late or non-fasting draw produces a result that cannot be matched to standard reference ranges.

Food intake creates a second source of testing error. Ingesting food before an appointment temporarily suppresses circulating testosterone. An afternoon appointment combined with a recent meal can pull a normal hormone reading into the hypogonadal range.

To prevent these errors, the Endocrine Society clinical practice guideline on hypogonadism recommends measuring total testosterone in the morning during a fasting state using a reliable assay. When testing total and free testosterone for low desire, book the earliest available morning slot. Fast overnight before the draw.

The Endocrine Society guideline also recommends confirming a low reading with a second, separate morning fasting measurement before diagnosing hypogonadism. A single low result does not confirm a permanent deficiency. A meaningful share of men who test low on an initial screening show normal concentrations when the draw is repeated under proper conditions.

Low Libido After Starting a GLP-1 Medication

Glucagon-like peptide-1 (GLP-1) receptor agonists do not list low libido as an official medication side effect, but early treatment frequently reduces sexual desire through rapid caloric restriction. Patients taking semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro) for weight loss and type 2 diabetes report reduced appetite and rapid fat loss. Dose titration often brings temporary nausea and fatigue.

Rapid, large-magnitude weight loss and a sustained caloric deficit independently reduce sex drive in both men and women. That nutritional drop suppresses sexual desire separately from any drug-specific chemical mechanism. Large-scale clinical trial data has not established a direct causal link between GLP-1 medications and sexual dysfunction.

Hormonal shifts during fat loss also affect men and women differently. In women, large reductions in body fat can lower circulating estrogen because adipose tissue provides active aromatization of androgens into estrogen. In men, large-magnitude weight loss improves insulin sensitivity and reduces aromatization, which can raise sex hormone-binding globulin (SHBG) and free testosterone over time.

In men, that hormonal shift can create a libido-positive effect over the longer term that differs from the early-titration period. Sexual dysfunction is not a labeled common side effect for semaglutide or tirzepatide. Patient reports remain anecdotal, and the topic remains an active area of ongoing study.

How to test testosterone at home

You don't need a lab appointment to check your own testosterone — a few at-home kits mail you a collection kit and return physician-reviewed results online within days:

Everlywell At-Home Testosterone Collection Kit for Men, Measures Total Testosterone Level for Accurate Results from CLIA-Certified Labs, Ages 18 Plus

Everlywell

View on Amazon →

EqualDx 3-in-1 Androgen Test – at-Home Sample Collection Kit | Measure Total T, Free (Active) T & SHBG for Wellness Tracking | CLIA Lab Tested | Painless Collection

EqualDx

View on Amazon →

Prefer to order direct? The Everlywell Testosterone Test uses a CLIA-certified lab, physician-reviewed results, and prepaid return shipping.